scholarly article | Q13442814 |
P356 | DOI | 10.1128/JVI.02745-05 |
P8608 | Fatcat ID | release_rfpkh5hzebd7jfjflhiclczosy |
P932 | PMC publication ID | 1489038 |
P698 | PubMed publication ID | 16809320 |
P50 | author | Mark Exley | Q67650208 |
P2093 | author name string | Petr O Ilyinskii | |
Steven P Balk | |||
Ruojie Wang | |||
P2860 | cites work | Role of CD1d-restricted NKT cells in microbial immunity | Q24294851 |
CD1: antigen presentation and T cell function | Q28251508 | ||
CD1 recognition by mouse NK1+ T lymphocytes | Q28591238 | ||
The CD1 system: antigen-presenting molecules for T cell recognition of lipids and glycolipids | Q33652486 | ||
Regulation of CD1d expression and function by a herpesvirus infection | Q33768331 | ||
Circulating Valpha24+Vbeta11+ NKT cell numbers and dendritic cell CD1d expression in hepatitis C virus infected patients. | Q42989825 | ||
Long-term loss of canonical NKT cells following an acute virus infection | Q43996244 | ||
Impaired clearance of herpes simplex virus type 1 from mice lacking CD1d or NKT cells expressing the semivariant V alpha 14-J alpha 281 TCR. | Q44285418 | ||
Does the gender difference in interferon production seen in picornavirus-infected spleen cell cultures from ICR Swiss mice have any in vivo significance? | Q44359318 | ||
Mechanisms of host defense following severe acute respiratory syndrome-coronavirus (SARS-CoV) pulmonary infection of mice | Q44412125 | ||
Innate immune response to encephalomyocarditis virus infection mediated by CD1d | Q44665307 | ||
Activation of a nonclassical NKT cell subset in a transgenic mouse model of hepatitis B virus infection | Q45732782 | ||
Generation of cellular immunity to lymphocytic choriomeningitis virus is independent of CD1d1 expression. | Q45734984 | ||
Heterosubtypic immunity to influenza A virus in mice lacking IgA, all Ig, NKT cells, or gamma delta T cells | Q45737098 | ||
CD1d-reactive T-cell activation leads to amelioration of disease caused by diabetogenic encephalomyocarditis virus | Q45737315 | ||
D variant of encephalomyocarditis virus (EMCV-D)-induced diabetes following natural killer cell depletion in diabetes-resistant male C57BL/6J mice | Q45851936 | ||
Antigen-presenting function of mouse CD1: one molecule with two different kinds of antigenic ligands. | Q46250608 | ||
CD1d1-dependent control of the magnitude of an acute antiviral immune response | Q47991973 | ||
Cytokines produced early in picornavirus infection reflect resistance or susceptibility to disease. | Q50867996 | ||
Natural Killer Cells Activated by MHC Class ILow Targets Prime Dendritic Cells to Induce Protective CD8 T Cell Responses | Q52005024 | ||
Tissue-specific segregation of CD1d-dependent and CD1d-independent NK T cells | Q59387571 | ||
Heterogeneity of NK1.1+ T cells in the bone marrow: divergence from the thymus | Q73160711 | ||
CD1d structure and regulation on human thymocytes, peripheral blood T cells, B cells and monocytes | Q73789797 | ||
Selective decrease in circulating V alpha 24+V beta 11+ NKT cells during HIV type 1 infection | Q77522486 | ||
Regulation of NKT cell development by SAP, the protein defective in XLP | Q81402277 | ||
Protection against lethal encephalomyocarditis virus infection in the absence of serum-neutralizing antibodies. | Q33784796 | ||
Selective loss of natural killer T cells by apoptosis following infection with lymphocytic choriomeningitis virus. | Q33848840 | ||
CD1d ligation on human monocytes directly signals rapid NF-kappaB activation and production of bioactive IL-12. | Q33920135 | ||
Diverse CD1d-restricted T cells: diverse phenotypes, and diverse functions | Q34123067 | ||
Nonclassical CD1d-restricted NK T cells that produce IL-13 characterize an atypical Th2 response in ulcerative colitis. | Q34321127 | ||
NK cells and NKT cells in innate defense against viral infections | Q34332682 | ||
Activation of natural killer (NK) T cells during murine cytomegalovirus infection enhances the antiviral response mediated by NK cells | Q34467874 | ||
Disseminated varicella infection due to the vaccine strain of varicella-zoster virus, in a patient with a novel deficiency in natural killer T cells | Q34542253 | ||
NK T cells contribute to expansion of CD8(+) T cells and amplification of antiviral immune responses to respiratory syncytial virus | Q34999264 | ||
The regulatory role of Valpha14 NKT cells in innate and acquired immune response. | Q35051569 | ||
Identification and simian immunodeficiency virus infection of CD1d-restricted macaque natural killer T cells | Q35104944 | ||
NKT cells and HIV infection | Q35206876 | ||
Shared modes of protection against poxvirus infection by attenuated and conventional smallpox vaccine viruses | Q35234767 | ||
CD1d-mediated antigen presentation to natural killer T (NKT) cells. | Q35696597 | ||
NKT cells and viral immunity | Q35798179 | ||
The immunoregulatory role of CD1d-restricted natural killer T cells in disease. | Q35811028 | ||
Picornavirus-specific CD4+ T lymphocytes possessing cytolytic activity confer protection in the absence of prophylactic antibodies | Q35844880 | ||
To be or not to be NKT: natural killer T cells in the liver. | Q35919440 | ||
Going both ways: immune regulation via CD1d-dependent NKT cells | Q35951531 | ||
Natural T cells: cranking up the immune system by prompt cytokine secretion | Q36216408 | ||
Dendritic cell-NK cell cross-talk: regulation and physiopathology. | Q36329065 | ||
Natural killer T cell activation inhibits hepatitis B virus replication in vivo. | Q36368956 | ||
CD1d-restricted human natural killer T cells are highly susceptible to human immunodeficiency virus 1 infection | Q36370230 | ||
Requirements for CD1d recognition by human invariant Valpha24+ CD4-CD8- T cells | Q36380304 | ||
Defective NKT cell development in mice and humans lacking the adapter SAP, the X-linked lymphoproliferative syndrome gene product | Q36402758 | ||
CD1d-mediated recognition of an alpha-galactosylceramide by natural killer T cells is highly conserved through mammalian evolution | Q36404242 | ||
Interleukin-15 and natural killer and NKT cells play a critical role in innate protection against genital herpes simplex virus type 2 infection. | Q36464621 | ||
Non-antigen-specific B-cell activation following murine gammaherpesvirus infection is CD4 independent in vitro but CD4 dependent in vivo. | Q39549238 | ||
Role of macrophages in the pathogenesis of encephalomyocarditis virus-induced diabetes in mice | Q40105452 | ||
Impaired cell surface expression of human CD1d by the formation of an HIV-1 Nef/CD1d complex. | Q40417308 | ||
African swine fever virus: a B cell-mitogenic virus in vivo and in vitro | Q40637246 | ||
Natural killer cells utilize both perforin and gamma interferon to regulate murine cytomegalovirus infection in the spleen and liver | Q40726486 | ||
Encephalomyocarditis and Mengo viruses productively infect murine T-lymphocyte cell lines but not fresh ex vivo derived T lymphocytes | Q40738454 | ||
A major fraction of human bone marrow lymphocytes are Th2-like CD1d-reactive T cells that can suppress mixed lymphocyte responses. | Q40769888 | ||
Diverse TCRs recognize murine CD1. | Q40981487 | ||
Mouse CD1-autoreactive T cells have diverse patterns of reactivity to CD1+ targets | Q41048706 | ||
Mouse CD1-specific NK1 T cells: development, specificity, and function | Q41464349 | ||
Distinct subsets of CD1d-restricted T cells recognize self-antigens loaded in different cellular compartments | Q41785389 | ||
A seek-and-hide game between Cd1-restricted T cells and herpesviruses | Q42727113 | ||
Specific antimononuclear phagocyte monoclonal antibodies. Application to the purification of dendritic cells and the tissue localization of macrophages | Q42936592 | ||
P433 | issue | 14 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | encephalomyocarditis virus | Q5375344 |
P304 | page(s) | 7146-7158 | |
P577 | publication date | 2006-07-01 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | CD1d mediates T-cell-dependent resistance to secondary infection with encephalomyocarditis virus (EMCV) in vitro and immune response to EMCV infection in vivo | |
P478 | volume | 80 |
Q33748552 | A comprehensive ex vivo functional analysis of human NKT cells reveals production of MIP1-α and MIP1-β, a lack of IL-17, and a Th1-bias in males |
Q37499317 | Antigen Presentation by CD1 Lipids, T Cells, and NKT Cells in Microbial Immunity |
Q38571656 | Contribution of autophagy to antiviral immunity. |
Q34550454 | Cross-talk between cd1d-restricted nkt cells and γδ cells in t regulatory cell response |
Q41858795 | Direct CD1d-mediated stimulation of APC IL-12 production and protective immune response to virus infection in vivo. |
Q42850482 | Herpes simplex virus 1 glycoprotein B and US3 collaborate to inhibit CD1d antigen presentation and NKT cell function |
Q57160792 | Herpes simplex virus-1 specifically targets human CD1d antigen presentation to enhance its pathogenicity |
Q35629455 | Histamine H(1) receptor signaling regulates effector T cell responses and susceptibility to coxsackievirus B3-induced myocarditis |
Q37462515 | Human cytomegalovirus (HCMV) US2 protein interacts with human CD1d (hCD1d) and down-regulates invariant NKT (iNKT) cell activity |
Q35841871 | Interleukin-22 is produced by invariant natural killer T lymphocytes during influenza A virus infection: potential role in protection against lung epithelial damages |
Q57831257 | NKT cell immune responses to viral infection |
Q37615203 | NKT cells: friend or foe during viral infections? |
Q33547424 | Paucity of CD4+ natural killer T (NKT) lymphocytes in sooty mangabeys is associated with lack of NKT cell depletion after SIV infection |
Q36540399 | The immune response to papillomavirus during infection persistence and regression |
Q37762343 | The invariant NKT cell subset in anti-viral defenses: a dark horse in anti-influenza immunity? |
Q27302768 | Tolerance and Cross-Tolerance following Toll-Like Receptor (TLR)-4 and -9 Activation Are Mediated by IRAK-M and Modulated by IL-7 in Murine Splenocytes |
Q35094156 | Type-specific human papillomavirus detection in cervical smears in Romania |
Q36994636 | Vesicular stomatitis virus matrix protein impairs CD1d-mediated antigen presentation through activation of the p38 MAPK pathway |
Q37880270 | What causes type 1 diabetes? Lessons from animal models |
Search more.